Eli Lilly And Co vs Teucrium Wheat Fund — how do they compare? Eli Lilly And Co trades at $1,179.3 (market cap $1.05T), while Teucrium Wheat Fund trades at $25.07. The key difference: Eli Lilly And Co pays a 0.59% dividend while Teucrium Wheat Fund pays none. Which is the better fit depends on your goals.
| LLY | WEAT | |
|---|---|---|
Market Cap | $1.05T | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $1.24K | $25.49 |
52-Week Low | $625.65 | $19.88 |
Enterprise Value | $1.09T | — |
Dividend Yield | 0.59% | — |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,179.09, up 0.76% with strong fundamental performance including 31.66% net income margin and three consecutive quarterly earnings beats. The stock shows neutral technical signals with bullish moving averages, while recent news highlights the $2.8 billion acquisition of AtaiBeckley to expand neuroscience pipeline. Revenue growth accelerated from $45.0B in 2024 to $65.2B in 2025, supporting premium valuation multiples.
LLY presents compelling growth prospects with analyst consensus target of $1,380 representing 17% upside, though elevated P/E of 41.89 and debt-to-asset ratio of 37.78% warrant caution. Key risks include acquisition integration challenges and regulatory scrutiny, while institutional sentiment remains strongly bullish with 73% buy ratings.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →